ARTICLE | Clinical News
Pulmazole gets QIDP, Fast Track designations from FDA
October 6, 2017 5:57 PM UTC
FDA granted Qualified Infectious Disease Product (QIDP) to Pulmazole (PUR1900) from Pulmatrix Inc. (NASDAQ:PULM) to treat pulmonary fungal infections in the lungs. Pulmazole is a dry powder formulati...
BCIQ Company Profiles